PT100511A - Uso de neurotrofina-4, processo de diagnostico baseado na expressao da mesma e producao de neurotrofina-4, e conjunto de diagnostico - Google Patents

Uso de neurotrofina-4, processo de diagnostico baseado na expressao da mesma e producao de neurotrofina-4, e conjunto de diagnostico Download PDF

Info

Publication number
PT100511A
PT100511A PT100511A PT10051192A PT100511A PT 100511 A PT100511 A PT 100511A PT 100511 A PT100511 A PT 100511A PT 10051192 A PT10051192 A PT 10051192A PT 100511 A PT100511 A PT 100511A
Authority
PT
Portugal
Prior art keywords
arg
ser
thr
seq
gly
Prior art date
Application number
PT100511A
Other languages
English (en)
Portuguese (pt)
Inventor
Nancy Ip
George D Yancopoulos
Original Assignee
Regeneron Pharma
Finn Hallbook
Carlos Fernando Ibanez Moliner
Hakan Bengt Persson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma, Finn Hallbook, Carlos Fernando Ibanez Moliner, Hakan Bengt Persson filed Critical Regeneron Pharma
Publication of PT100511A publication Critical patent/PT100511A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Toys (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PT100511A 1991-05-21 1992-05-21 Uso de neurotrofina-4, processo de diagnostico baseado na expressao da mesma e producao de neurotrofina-4, e conjunto de diagnostico PT100511A (pt)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US70345091A 1991-05-21 1991-05-21
US72925391A 1991-07-12 1991-07-12
US73442291A 1991-07-23 1991-07-23
US75135691A 1991-08-28 1991-08-28
US76267491A 1991-09-20 1991-09-20
US79192491A 1991-11-14 1991-11-14

Publications (1)

Publication Number Publication Date
PT100511A true PT100511A (pt) 1993-09-30

Family

ID=27560239

Family Applications (1)

Application Number Title Priority Date Filing Date
PT100511A PT100511A (pt) 1991-05-21 1992-05-21 Uso de neurotrofina-4, processo de diagnostico baseado na expressao da mesma e producao de neurotrofina-4, e conjunto de diagnostico

Country Status (8)

Country Link
EP (1) EP0587806A4 (fr)
JP (1) JPH08510987A (fr)
AU (1) AU674659B2 (fr)
CA (1) CA2109598A1 (fr)
IE (1) IE921636A1 (fr)
NZ (1) NZ242813A (fr)
PT (1) PT100511A (fr)
WO (1) WO1992020365A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE140966T1 (de) * 1990-09-25 1996-08-15 Genentech Inc Neuer neurotropischer faktor
ATE154389T1 (de) 1991-02-18 1997-06-15 Takeda Chemical Industries Ltd Verfahren zur herstellung von menschlichem ngf-2
WO1993025684A1 (fr) * 1992-06-12 1993-12-23 Regeneron Pharmaceuticals, Inc. Procedes therapeutique et diagnostique bases sur l'expression de la neurotrophine-4
FI991197A0 (fi) * 1999-05-27 1999-05-27 Mart Saarma Neurotrooppiset tekijät lantionalueen ääreishermoston toimintahäiriön hoitamisessa

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169764A (en) * 1990-08-08 1992-12-08 Regeneron Pharmaceuticals, Inc. Multitrophic and multifunctional chimeric neurotrophic factors, and nucleic acids and plasmids encoding the chimeras
ATE140966T1 (de) * 1990-09-25 1996-08-15 Genentech Inc Neuer neurotropischer faktor
IL101661A (en) * 1991-04-23 1998-02-08 Regeneron Pharma Method for detecting, identifying or measuring agents having neurotrophin activity

Also Published As

Publication number Publication date
JPH08510987A (ja) 1996-11-19
NZ242813A (en) 1996-09-25
CA2109598A1 (fr) 1992-11-26
AU2302192A (en) 1992-12-30
WO1992020365A1 (fr) 1992-11-26
IE921636A1 (en) 1992-12-02
EP0587806A1 (fr) 1994-03-23
EP0587806A4 (fr) 1995-04-26
AU674659B2 (en) 1997-01-09

Similar Documents

Publication Publication Date Title
US5229500A (en) Brain derived neurotrophic factor
CA2040437C (fr) Neurotrophine-3, nouveau facteur neurotrophique lie au facteur de croissance du tissu nerveux et au facteur neurotrophique derive du cerveau
US5180820A (en) Brain-derived neurotrophic factor
FI117556B (fi) Yhdistelmä-DNA-menetelmä hermoston tukikudosperäisen neurotrofisen tekijän tuottamiseksi
Burke et al. Loss of developing cholinergic basal forebrain neurons following excitotoxic lesions of the hippocampus: rescue by neurotrophins
HK1006578B (en) Brain derived neurotrophic factor
EP0542892A1 (fr) Facteurs neurotrophiques chimeriques
HK1006579B (en) Neurotrophin-3, a novel neurotrophic factor related to nerve growth factor and brain derived neurotrophic factor
AU4535993A (en) Therapeutic and diagnostic methods based on neurotrophin-4 expression
US20020164702A1 (en) Novel tyrosine kinase receptors and ligands
PT100511A (pt) Uso de neurotrofina-4, processo de diagnostico baseado na expressao da mesma e producao de neurotrofina-4, e conjunto de diagnostico
WO1993001300A1 (fr) Methodes de traitement de maladies des neurones moteurs utilisant des elements de la famille des molecules bdnf/nt-3/ngf
Rushlow et al. Characterization of CArG-binding protein A initially identified by differential display
US6933276B1 (en) Methods of treating peripheral neuropathies using neurotrophin-3
PT101064A (pt) Proteinas e peptidos prepro quimericos, moleculas de acido nucleico que os codificam, e processo de producao de uma neurotrofina
NZ270485A (en) Diagnosis of motor neuron disease using neurotrophin-4 (nt-4) and methods for measuring its activity
WO1994009765A1 (fr) Interactions fonctionnelles entre le s-100b glial et les neurones serotoninergiques du systeme nerveux central
Snyder Expression of themRNA encoding VGF, a neural-specific peptide precursor, in the developing and adult rat central nervous systems, and its modulation in response to changes in neuronal electrical activity, seizure, and lesion
Bishop Regulatory mechanisms involved in the expression of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19930317

FC3A Refusal

Effective date: 19990407